Correlation Between Takeda Pharmaceutical and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and Crispr Therapeutics AG, you can compare the effects of market volatilities on Takeda Pharmaceutical and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Crispr Therapeutics.
Diversification Opportunities for Takeda Pharmaceutical and Crispr Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Takeda and Crispr is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Takeda Pharmaceutical and Crispr Therapeutics
Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to under-perform the Crispr Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical Co is 3.18 times less risky than Crispr Therapeutics. The stock trades about -0.11 of its potential returns per unit of risk. The Crispr Therapeutics AG is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 4,552 in Crispr Therapeutics AG on September 2, 2024 and sell it today you would earn a total of 565.00 from holding Crispr Therapeutics AG or generate 12.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Takeda Pharmaceutical Co vs. Crispr Therapeutics AG
Performance |
| Timeline |
| Takeda Pharmaceutical |
| Crispr Therapeutics |
Takeda Pharmaceutical and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Takeda Pharmaceutical and Crispr Therapeutics
The main advantage of trading using opposite Takeda Pharmaceutical and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| Takeda Pharmaceutical vs. Viatris | Takeda Pharmaceutical vs. Elanco Animal Health | Takeda Pharmaceutical vs. Zoetis Inc | Takeda Pharmaceutical vs. Emergent Biosolutions |
| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |